Literature DB >> 24646836

Olfactory function in migraine both during and between attacks.

Michael J Marmura1, Teshamae S Monteith2, Waseem Anjum3, Richard L Doty4, Sarah E Hegarty5, Scott W Keith5.   

Abstract

INTRODUCTION: People with migraine often report being osmophobic, both during and between acute migraine attacks. It is not clear, however, whether such reports are associated with changes in olfaction such as hyperosmia, as measured by psychophysical testing. In this case-control study we quantitatively assessed olfactory identification ability, which correlates with threshold tests of olfactory acuity, in patients with migraine at baseline (no headache), during migraine episodes, and after a treated attack and compared the test scores to those of matched control subjects.
METHODS: Fifty episodic migraine subjects and 50 and sex- and age-matched controls without headache were tested. All completed the University of Pennsylvania Smell Identification Test (UPSIT), a standardized and well-validated olfactory test.
RESULTS: At baseline, the UPSIT scores did not differ significantly between the migraine and control study groups (median paired score difference: -1, p = 0.18). During migraine attacks, a minority of migraine subjects (eight of 42) developed microsmia (i.e. lower test scores by at least four points), suggesting that, as compared to their matched controls, olfactory acuity was somewhat impaired during migraine attacks (p = 0.02). This difference was less pronounced and not statistically significant after a successfully treated attack (p = 0.15). DISCUSSION: People with episodic migraine were found to have similar olfactory function as age- and sex-matched controls, but a minority exhibit microsmia or hyposmia during acute attacks. The cause of this dysfunction is unknown, but could relate to autonomic symptoms, limbic system activation, or disorders of higher order sensory processing. © International Headache Society 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Migraine; allodynia; episodic migraine; olfaction; osmophobia

Mesh:

Year:  2014        PMID: 24646836     DOI: 10.1177/0333102414527014

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

Review 1.  The Insula: A "Hub of Activity" in Migraine.

Authors:  David Borsook; Rosanna Veggeberg; Nathalie Erpelding; Ronald Borra; Clas Linnman; Rami Burstein; Lino Becerra
Journal:  Neuroscientist       Date:  2015-08-19       Impact factor: 7.519

2.  Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking.

Authors:  James D Sharer; Fidias E Leon-Sarmiento; James F Morley; Daniel Weintraub; Richard L Doty
Journal:  Mov Disord       Date:  2014-12-27       Impact factor: 10.338

3.  Osmophobia in allodynic migraineurs: cause or consequence of central sensitization?

Authors:  C Lovati; L Giani; D Castoldi; C Mariotti D'Alessandro; F DeAngeli; E Capiluppi; D D'Amico; C Mariani
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

4.  Clinical significance of osmophobia and its effect on quality of life in people with migraine.

Authors:  Emine Meşe Pekdemir; Nermin Tanik
Journal:  Acta Neurol Belg       Date:  2022-07-21       Impact factor: 2.471

Review 5.  Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field.

Authors:  Antonia Ferrer-Torres; Lydia Giménez-Llort
Journal:  Int J Environ Res Public Health       Date:  2022-06-01       Impact factor: 4.614

6.  Osmophobia and olfactory functions in patients with migraine.

Authors:  Gürkan Kayabaşoglu; Aytug Altundag; Dilcan Kotan; Denizhan Dizdar; Recep Kaymaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-30       Impact factor: 2.503

7.  The First Report of CADASIL in Peru: Olfactory Dysfunction on Initial Presentation.

Authors:  Anastasia Vishnevetsky; Miguel Inca-Martinez; Karina Milla-Neyra; Danny Moises Barrientos-Iman; Ivan Cornejo-Herrera; Carlos Cosentino; Mario Cornejo-Olivas
Journal:  eNeurologicalSci       Date:  2016-09-28

Review 8.  Pathophysiology and Therapy of Associated Features of Migraine.

Authors:  Maria Dolores Villar-Martinez; Peter J Goadsby
Journal:  Cells       Date:  2022-09-05       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.